Therapeutic agents

Details for Australian Patent Application No. 2005229459 (hide)

Owner AstraZeneca AB

Inventors Lindstedt-Alstermark, Eva-Lotte; Boije, Anna Maria Persdotter; Cheng, Leifeng

Agent Davies Collison Cave

Pub. Number AU-B-2005229459

PCT Pub. Number WO2005/095354

Priority 0407671.7 03.04.04 GB; 0420781.7 18.09.04 GB

Filing date 30 March 2005

Wipo publication date 13 October 2005

Acceptance publication date 25 September 2008

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 233/66 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/095354 Priority application(s): WO2005/095354

25 September 2008 Application Accepted

  Published as AU-B-2005229459

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005229466-Artificial intervertebral disk

2005229457-Immunoglobulins